LOGIN
AAOS 2024: Comparing Intra-Articular & Intravenous Route of Tranexamic Acid During Hip Replacement
February 2024
AAOS 2024: Comparing Intra-Articular & Intravenous Route of Tranexamic Acid During Hip Replacement
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Comparing intra-articular and intravenous route of tranexamic acid administration and evaluating its efficacy in preventing blood loss during hip replacement surgery
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
120 patients undergoing hip replacement surgery were randomized to receive either intravenous tranexamic acid (IV TXA), intra-articular TXA (TXA local), or placebo. Outcomes of interest included postoperative hemoglobin and hematocrit decline, transfusion rates, and the incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), and wound infection rates. The results showed that perioperativ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.